Jasper Therapeutics, Inc. (JSPR)
Nasdaq: JSPR · CIK 0001788028 · United States
Every official Jasper Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open JSPR filings
Jasper Therapeutics, Inc. documents
- Jasper Therapeutics, Inc. 10-K 2026JSPR 10-K 2026: annual report for fiscal 2026
- Jasper Therapeutics, Inc. 10-K 2025JSPR 10-K 2025: annual report for fiscal 2025
- Jasper Therapeutics, Inc. 10-K 2024JSPR 10-K 2024: annual report for fiscal 2024
- Jasper Therapeutics, Inc. 10-K 2023JSPR 10-K 2023: annual report for fiscal 2023
- Jasper Therapeutics, Inc. 10-K 2022JSPR 10-K 2022: annual report for fiscal 2022
- Jasper Therapeutics, Inc. 10-Q 2026JSPR 10-Q 2026: quarterly report for fiscal 2026
- Jasper Therapeutics, Inc. 10-Q 2025JSPR 10-Q 2025: quarterly report for fiscal 2025
- Jasper Therapeutics, Inc. 10-Q 2024JSPR 10-Q 2024: quarterly report for fiscal 2024
- Jasper Therapeutics, Inc. 10-Q 2023JSPR 10-Q 2023: quarterly report for fiscal 2023
- Jasper Therapeutics, Inc. 10-Q 2022JSPR 10-Q 2022: quarterly report for fiscal 2022
- Jasper Therapeutics, Inc. 8-K 2026JSPR 8-K 2026: current report for fiscal 2026
- Jasper Therapeutics, Inc. 8-K 2025JSPR 8-K 2025: current report for fiscal 2025
- Jasper Therapeutics, Inc. 8-K 2024JSPR 8-K 2024: current report for fiscal 2024
- Jasper Therapeutics, Inc. 8-K 2023JSPR 8-K 2023: current report for fiscal 2023
- Jasper Therapeutics, Inc. 8-K 2022JSPR 8-K 2022: current report for fiscal 2022
- Jasper Therapeutics, Inc. DEF 14A 2026JSPR DEF 14A 2026: proxy statement for fiscal 2026
- Jasper Therapeutics, Inc. DEF 14A 2025JSPR DEF 14A 2025: proxy statement for fiscal 2025
- Jasper Therapeutics, Inc. DEF 14A 2024JSPR DEF 14A 2024: proxy statement for fiscal 2024
- Jasper Therapeutics, Inc. DEF 14A 2023JSPR DEF 14A 2023: proxy statement for fiscal 2023
- Jasper Therapeutics, Inc. DEF 14A 2022JSPR DEF 14A 2022: proxy statement for fiscal 2022
- Jasper Therapeutics, Inc. Form 4 2026JSPR Form 4 2026: insider trading filing for fiscal 2026
- Jasper Therapeutics, Inc. Form 4 2025JSPR Form 4 2025: insider trading filing for fiscal 2025
- Jasper Therapeutics, Inc. Form 4 2024JSPR Form 4 2024: insider trading filing for fiscal 2024
- Jasper Therapeutics, Inc. Form 4 2023JSPR Form 4 2023: insider trading filing for fiscal 2023
- Jasper Therapeutics, Inc. Form 4 2022JSPR Form 4 2022: insider trading filing for fiscal 2022
- Jasper Therapeutics, Inc. S-1 2026JSPR S-1 2026: registration statement for fiscal 2026
- Jasper Therapeutics, Inc. S-1 2025JSPR S-1 2025: registration statement for fiscal 2025
- Jasper Therapeutics, Inc. S-1 2024JSPR S-1 2024: registration statement for fiscal 2024
- Jasper Therapeutics, Inc. S-1 2023JSPR S-1 2023: registration statement for fiscal 2023
- Jasper Therapeutics, Inc. S-1 2022JSPR S-1 2022: registration statement for fiscal 2022
- Jasper Therapeutics, Inc. 13F 2026JSPR 13F 2026: institutional holdings for fiscal 2026
- Jasper Therapeutics, Inc. 13F 2025JSPR 13F 2025: institutional holdings for fiscal 2025
- Jasper Therapeutics, Inc. 13F 2024JSPR 13F 2024: institutional holdings for fiscal 2024
- Jasper Therapeutics, Inc. 13F 2023JSPR 13F 2023: institutional holdings for fiscal 2023
- Jasper Therapeutics, Inc. 13F 2022JSPR 13F 2022: institutional holdings for fiscal 2022
More companies